1. Home
  2. WKHS vs APM Comparison

WKHS vs APM Comparison

Compare WKHS & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$0.78

Market Cap

17.4M

ML Signal

HOLD

Logo Aptorum Group Limited

APM

Aptorum Group Limited

HOLD

Current Price

$1.34

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKHS
APM
Founded
2007
2010
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
18.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
WKHS
APM
Price
$0.78
$1.34
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$1.75
N/A
AVG Volume (30 Days)
4.1M
109.4K
Earning Date
11-10-2025
12-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,620,296.00
N/A
Revenue This Year
$92.70
N/A
Revenue Next Year
$34.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.73
N/A
52 Week Low
$0.53
$0.65
52 Week High
$15.75
$7.49

Technical Indicators

Market Signals
Indicator
WKHS
APM
Relative Strength Index (RSI) 43.86 43.44
Support Level $0.79 $1.27
Resistance Level $0.90 $1.38
Average True Range (ATR) 0.14 0.14
MACD 0.01 0.01
Stochastic Oscillator 45.67 21.57

Price Performance

Historical Comparison
WKHS
APM

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Share on Social Networks: